Abstract |
The heart rate increase induced by dynamic exercise in patients with chronic atrial fibrillation is competitively attenuated by beta-blockade. The influence of oral celiprolol on exercise induced tachycardia was evaluated in 23 patients with chronic stable atrial fibrillation in a dose-titration study. This was succeeded by a placebo-controlled double-blind, crossover multi-center trial. During the dose-titration phase each patient underwent a single-blind three week dose escalation period-taking celiprolol 200 mg once daily for one week, celiprolol 400 mg once daily for the third week. After a one week placebo washout, patients then entered a double-blind crossover phase, consisting of one week each of placebo or celiprolol according to a pre-determined randomization. After one week of placebo washout, each patient was crossed-over. In 21 patients celiprolol reduces exercise-induced increased heart rate by approximately 35% when compared with placebo. These results indicate that celiprolol should be effective in controlling the exercise-induced increase in heart rate in patients with chronic atrial fibrillation. In addition, results of 24 h ambulatory ECG monitoring (Holtor monitoring) indicate that celiprolol reduces the ventricular premature contractions.
|
Authors | S K Lin, J Morganroth, M Heng, S Rubler, W Baird, J E Atwood, N Mostow, O M Scarse, P Yu, F S Caruso |
Journal | Journal of cardiovascular pharmacology
(J Cardiovasc Pharmacol)
Vol. 8 Suppl 4
Pg. S112-5
( 1986)
ISSN: 0160-2446 [Print] United States |
PMID | 2427838
(Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial)
|
Chemical References |
- Propanolamines
- Celiprolol
|
Topics |
- Administration, Oral
- Aged
- Atrial Fibrillation
(drug therapy)
- Celiprolol
- Clinical Trials as Topic
- Electrocardiography
- Exercise Test
- Female
- Humans
- Male
- Middle Aged
- Propanolamines
(administration & dosage, therapeutic use)
|